
Blog
PNI Publishes 13-Year Study on Less Invasive Brain Surgery
by Amelia Garrison
A recent Pacific Neuroscience Institute (PNI) publication may help neurosurgeons to apply less invasive techniques in brain tumor removal.
Streamlining Brain Tumor Surgery Care During the Pandemic
by Guest Author
During COVID-19, Pacific Neuroscience Institute sets new standard of safe, efficient, high quality minimally invasive brain tumor surgery. Find out more.
Achieving Better Outcomes in Endoscopic Pituitary Adenoma Surgery
by PNI Experts
Pacific Neuroscience Institute at Providence Saint John’s Strives to Set a New Standard in Landmark 10-year Study in over 500 Patients with Focus on Complication Avoidance. Findings published in this month’s “Pituitary” journal SANTA MONICA, Calif., July 8, 2021— Intense focus on avoiding complications in...
PNI’s 2020 Year-in-Review & What To Expect in 2021
by Zara Jethani
PNI’s Year-in-Review 2020 was, despite the pandemic, a strong year for clinical care delivered by PNI providers with multiple milestones being achieved. We’ve entered 2021 with a deep commitment to treating our patients at our ten centers of excellence, doing groundbreaking research, providing innovative clinical...
Brain Surgery Through the Eyebrow
by Daniel F. Kelly
An excellent team of outstanding neurosurgeons at Pacific Neuroscience Institute’s Brain Tumor Center has reported on 129 minimally invasive supraorbital (SO) surgeries in a recent paper; the highly encouraging results of a retrospective study are discussed. Minimally Invasive Surgery for Removal of Brain and Skull...
When a Good Protein Goes Bad: Cdk5’s Role in Neurodegenerative Disease
by Guest Author
Neurodegenerative disease is a broad term for a range of conditions which mostly affect neurons in the human brain. Currently, 5 million Americans suffer from Alzheimer's disease; 1 million from Parkinson's disease; and 30,000 from Huntington's disease.
Biopsy-Free Analysis of Brain Cancer
by Achal S. Achrol
A recently published paper by Pacific Neuroscience Institute researchers suggests a promising new approach for a biopsy-free method to identify primary brain tumor genetics for personalized treatment options.
Nanoparticles as a Next-Generation Drug Delivery In Cancer Treatment
by Guest Author
Nanotechnology is a compelling new drug delivery method in oncology where nanoparticles are engineered to target therapeutics to kill cancer. Find out more in Dr. Venkata Yenugonda's review article in the March 2019 issue International Journal of Nanomedicine.
Pregnancy Could Be Linked to Onset of Cushing’s Symptoms, Retrospective Study Suggests
by Guest Author
More than 25 percent of women with Cushing’s disease experienced their first symptoms within one year of giving birth, a small study by researchers at Pacific Neuroscience Institute found.



Keeping Cerebrospinal Fluid Leaks and Meningitis at Bay
by Daniel F. Kelly
Keeping Cerebrospinal Fluid Leaks and Meningitis at Bay. Defining the optimal exit strategy in pituitary and skull base tumor surgery, PNI authors have published a landmark article in the May 2018 issue of Journal of Neurosurgery. Leading the way in the field of minimally invasive surgery, PNI’s expert team reported on intraoperative repair of skull base defects and prevention of post-operative CSF leaks and meningitis in over 500 patients with pituitary tumors and skull base tumors.
Last updated: January 14th, 2019